Morgan Stanley and Capital Research Global Investors lifted their positions in Eli Lilly, while Cantor Fitzgerald provided new research reports on the stock.
4 reports, 3 independent
Updated Sep 9
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley and Capital Research Global Investors lifted their positions in Eli Lilly, while Cantor Fitzgerald provided new research reports on the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Morgan Stanley
U.S. investment bank
-
Capital Research Global Investors
Nothing else this week.